| ENSG00000234323.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030943112 |
Resistant |
| ENSG00000235123.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022762279 |
Resistant |
| ENSG00000247844.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028063244 |
Resistant |
| ENSG00000250582.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040254988 |
Resistant |
| ENSG00000261019.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04287124 |
Resistant |
| ENSG00000266987.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022889027 |
Resistant |
| ENSG00000203721.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.03573342 |
Resistant |
| ENSG00000227258.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.044974481 |
Resistant |
| ENSG00000230753.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.033231398 |
Resistant |
| ENSG00000258303.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.036563079 |
Resistant |
| ENSG00000261468.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.0471811 |
Resistant |
| ENSG00000265743.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049011303 |
Resistant |
| ENSG00000267199.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.045923591 |
Resistant |
| ENSG00000272745.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012781045 |
Resistant |
| ENSG00000273186.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.02563298 |
Resistant |
| ENSG00000204241.3 |
Bortezomib |
Brain lower grade glioma |
0.032480811 |
Resistant |
| ENSG00000206195.6 |
Bortezomib |
Brain lower grade glioma |
0.026045783 |
Resistant |
| ENSG00000215039.2 |
Bortezomib |
Brain lower grade glioma |
0.009129998 |
Resistant |
| ENSG00000224799.1 |
Bortezomib |
Brain lower grade glioma |
0.011250436 |
Resistant |
| ENSG00000225602.1 |
Bortezomib |
Brain lower grade glioma |
0.027481508 |
Resistant |
| ENSG00000225806.3 |
Bortezomib |
Brain lower grade glioma |
0.03552332 |
Resistant |
| ENSG00000227542.1 |
Bortezomib |
Brain lower grade glioma |
0.022908752 |
Resistant |
| ENSG00000228527.1 |
Bortezomib |
Brain lower grade glioma |
0.042175549 |
Resistant |
| ENSG00000228629.2 |
Bortezomib |
Brain lower grade glioma |
0.019124587 |
Resistant |
| ENSG00000228679.1 |
Bortezomib |
Brain lower grade glioma |
0.04021713 |
Resistant |
| ENSG00000228802.1 |
Bortezomib |
Brain lower grade glioma |
0.026881033 |
Resistant |
| ENSG00000228939.1 |
Bortezomib |
Brain lower grade glioma |
0.017368713 |
Resistant |
| ENSG00000229582.2 |
Bortezomib |
Brain lower grade glioma |
0.008062504 |
Resistant |
| ENSG00000230534.2 |
Bortezomib |
Brain lower grade glioma |
0.032105893 |
Resistant |
| ENSG00000230894.1 |
Bortezomib |
Brain lower grade glioma |
0.033702083 |
Resistant |
| ENSG00000231724.1 |
Bortezomib |
Brain lower grade glioma |
0.010942173 |
Resistant |
| ENSG00000232721.1 |
Bortezomib |
Brain lower grade glioma |
0.007920435 |
Resistant |
| ENSG00000233825.1 |
Bortezomib |
Brain lower grade glioma |
0.040138767 |
Resistant |
| ENSG00000234771.2 |
Bortezomib |
Brain lower grade glioma |
0.035073239 |
Resistant |
| ENSG00000235586.1 |
Bortezomib |
Brain lower grade glioma |
0.009415841 |
Resistant |
| ENSG00000236144.2 |
Bortezomib |
Brain lower grade glioma |
0.023775853 |
Resistant |
| ENSG00000236308.1 |
Bortezomib |
Brain lower grade glioma |
0.016675928 |
Resistant |
| ENSG00000237328.1 |
Bortezomib |
Brain lower grade glioma |
0.044965125 |
Resistant |
| ENSG00000237410.1 |
Bortezomib |
Brain lower grade glioma |
0.047100062 |
Resistant |
| ENSG00000237927.1 |
Bortezomib |
Brain lower grade glioma |
0.031989297 |
Resistant |
| ENSG00000241219.1 |
Bortezomib |
Brain lower grade glioma |
0.008667306 |
Resistant |
| ENSG00000245685.2 |
Bortezomib |
Brain lower grade glioma |
0.009876405 |
Resistant |
| ENSG00000245857.2 |
Bortezomib |
Brain lower grade glioma |
0.038155844 |
Resistant |
| ENSG00000247624.2 |
Bortezomib |
Brain lower grade glioma |
0.028005768 |
Resistant |
| ENSG00000248936.1 |
Bortezomib |
Brain lower grade glioma |
0.04298314 |
Resistant |
| ENSG00000249417.1 |
Bortezomib |
Brain lower grade glioma |
0.029133456 |
Resistant |
| ENSG00000249791.1 |
Bortezomib |
Brain lower grade glioma |
0.005875143 |
Resistant |
| ENSG00000250159.2 |
Bortezomib |
Brain lower grade glioma |
0.036455301 |
Resistant |
| ENSG00000251175.1 |
Bortezomib |
Brain lower grade glioma |
0.01831562 |
Resistant |
| ENSG00000251523.1 |
Bortezomib |
Brain lower grade glioma |
0.049852457 |
Resistant |
| ENSG00000255670.1 |
Bortezomib |
Brain lower grade glioma |
0.011477841 |
Resistant |
| ENSG00000256603.1 |
Bortezomib |
Brain lower grade glioma |
0.038608907 |
Resistant |
| ENSG00000257176.1 |
Bortezomib |
Brain lower grade glioma |
0.015274989 |
Resistant |
| ENSG00000257366.1 |
Bortezomib |
Brain lower grade glioma |
0.037645515 |
Resistant |
| ENSG00000257391.1 |
Bortezomib |
Brain lower grade glioma |
0.018082634 |
Resistant |
| ENSG00000257563.1 |
Bortezomib |
Brain lower grade glioma |
0.027324343 |
Resistant |
| ENSG00000258323.1 |
Bortezomib |
Brain lower grade glioma |
0.043878451 |
Resistant |
| ENSG00000258354.1 |
Bortezomib |
Brain lower grade glioma |
0.022927257 |
Resistant |
| ENSG00000258766.1 |
Bortezomib |
Brain lower grade glioma |
0.00333003 |
Resistant |
| ENSG00000259187.1 |
Bortezomib |
Brain lower grade glioma |
0.038079234 |
Resistant |
| ENSG00000259364.1 |
Bortezomib |
Brain lower grade glioma |
0.005269894 |
Resistant |
| ENSG00000259448.2 |
Bortezomib |
Brain lower grade glioma |
0.040850493 |
Resistant |
| ENSG00000259453.1 |
Bortezomib |
Brain lower grade glioma |
0.045181323 |
Resistant |
| ENSG00000259488.1 |
Bortezomib |
Brain lower grade glioma |
0.016193406 |
Resistant |
| ENSG00000259520.1 |
Bortezomib |
Brain lower grade glioma |
0.025159303 |
Resistant |
| ENSG00000259561.1 |
Bortezomib |
Brain lower grade glioma |
0.03821166 |
Resistant |
| ENSG00000259589.2 |
Bortezomib |
Brain lower grade glioma |
0.035977118 |
Resistant |
| ENSG00000259618.1 |
Bortezomib |
Brain lower grade glioma |
0.044056389 |
Resistant |
| ENSG00000259668.1 |
Bortezomib |
Brain lower grade glioma |
0.035496767 |
Resistant |
| ENSG00000259818.1 |
Bortezomib |
Brain lower grade glioma |
0.042041286 |
Resistant |
| ENSG00000259994.1 |
Bortezomib |
Brain lower grade glioma |
0.027122222 |
Resistant |
| ENSG00000260196.1 |
Bortezomib |
Brain lower grade glioma |
0.029278271 |
Resistant |
| ENSG00000260369.2 |
Bortezomib |
Brain lower grade glioma |
0.04364937 |
Resistant |
| ENSG00000260396.1 |
Bortezomib |
Brain lower grade glioma |
0.034659418 |
Resistant |
| ENSG00000260583.1 |
Bortezomib |
Brain lower grade glioma |
0.049180735 |
Resistant |
| ENSG00000260633.1 |
Bortezomib |
Brain lower grade glioma |
0.035906472 |
Resistant |
| ENSG00000260672.1 |
Bortezomib |
Brain lower grade glioma |
0.023195562 |
Resistant |
| ENSG00000261167.1 |
Bortezomib |
Brain lower grade glioma |
0.017190767 |
Resistant |
| ENSG00000261770.1 |
Bortezomib |
Brain lower grade glioma |
0.033326853 |
Resistant |
| ENSG00000261886.1 |
Bortezomib |
Brain lower grade glioma |
0.029211871 |
Resistant |
| ENSG00000262222.1 |
Bortezomib |
Brain lower grade glioma |
0.017881523 |
Resistant |
| ENSG00000263013.1 |
Bortezomib |
Brain lower grade glioma |
0.028005858 |
Resistant |
| ENSG00000263350.1 |
Bortezomib |
Brain lower grade glioma |
0.032609075 |
Resistant |
| ENSG00000265094.1 |
Bortezomib |
Brain lower grade glioma |
0.01824501 |
Resistant |
| ENSG00000267786.1 |
Bortezomib |
Brain lower grade glioma |
0.040751227 |
Resistant |
| ENSG00000268573.1 |
Bortezomib |
Brain lower grade glioma |
0.030976006 |
Resistant |
| ENSG00000268889.1 |
Bortezomib |
Brain lower grade glioma |
0.027151931 |
Resistant |
| ENSG00000269893.2 |
Bortezomib |
Brain lower grade glioma |
0.019733269 |
Resistant |
| ENSG00000269938.1 |
Bortezomib |
Brain lower grade glioma |
0.029263082 |
Resistant |
| ENSG00000270091.1 |
Bortezomib |
Brain lower grade glioma |
0.013913488 |
Resistant |
| ENSG00000270100.1 |
Bortezomib |
Brain lower grade glioma |
0.043972743 |
Resistant |
| ENSG00000270462.1 |
Bortezomib |
Brain lower grade glioma |
0.029222209 |
Resistant |
| ENSG00000271335.1 |
Bortezomib |
Brain lower grade glioma |
0.029649792 |
Resistant |
| ENSG00000271849.1 |
Bortezomib |
Brain lower grade glioma |
0.047135923 |
Resistant |
| ENSG00000271964.1 |
Bortezomib |
Brain lower grade glioma |
0.015263868 |
Resistant |
| ENSG00000272076.1 |
Bortezomib |
Brain lower grade glioma |
0.03049868 |
Resistant |
| ENSG00000272368.1 |
Bortezomib |
Brain lower grade glioma |
0.011966175 |
Resistant |
| ENSG00000272777.1 |
Bortezomib |
Brain lower grade glioma |
0.025355927 |
Resistant |
| ENSG00000272828.1 |
Bortezomib |
Brain lower grade glioma |
0.036643689 |
Resistant |
| ENSG00000272914.1 |
Bortezomib |
Brain lower grade glioma |
0.048827407 |
Resistant |
| ENSG00000273156.1 |
Bortezomib |
Brain lower grade glioma |
0.039265311 |
Resistant |
| ENSG00000273237.1 |
Bortezomib |
Brain lower grade glioma |
0.031310377 |
Resistant |
| ENSG00000273290.1 |
Bortezomib |
Brain lower grade glioma |
0.030526382 |
Resistant |
| ENSG00000273403.1 |
Bortezomib |
Brain lower grade glioma |
0.047641609 |
Resistant |
| ENSG00000273449.1 |
Bortezomib |
Brain lower grade glioma |
0.011902821 |
Resistant |
| ENSG00000196553.9 |
Bortezomib |
Lung squamous cell carcinoma |
0.028676926 |
Resistant |
| ENSG00000204934.6 |
Bortezomib |
Lung squamous cell carcinoma |
0.032616211 |
Resistant |
| ENSG00000227237.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.00335505 |
Resistant |
| ENSG00000230798.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.039310917 |
Resistant |
| ENSG00000230826.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.012100134 |
Resistant |
| ENSG00000232445.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.036516691 |
Resistant |
| ENSG00000234264.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.018959384 |
Resistant |
| ENSG00000235096.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.040636099 |
Resistant |
| ENSG00000250012.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.016806766 |
Resistant |
| ENSG00000254208.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.023973289 |
Resistant |
| ENSG00000254538.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.029469241 |
Resistant |
| ENSG00000254821.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.0000367 |
Resistant |
| ENSG00000256196.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.037654804 |
Resistant |
| ENSG00000256325.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.00491702 |
Resistant |
| ENSG00000257568.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.042448384 |
Resistant |
| ENSG00000257910.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.029626132 |
Resistant |
| ENSG00000259407.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.024032189 |
Resistant |
| ENSG00000261170.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.04491641 |
Resistant |
| ENSG00000267798.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.026431 |
Resistant |
| ENSG00000270742.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.003620863 |
Resistant |
| ENSG00000272754.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.012283541 |
Resistant |
| ENSG00000272871.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.009838848 |
Resistant |
| ENSG00000273084.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.041700395 |
Resistant |
| ENSG00000273216.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.028947713 |
Resistant |
| ENSG00000223882.1 |
Bortezomib |
Skin cutaneous melanoma |
0.01006931 |
Resistant |
| ENSG00000224621.1 |
Bortezomib |
Skin cutaneous melanoma |
0.018109493 |
Resistant |
| ENSG00000224844.1 |
Bortezomib |
Skin cutaneous melanoma |
0.033627134 |
Resistant |
| ENSG00000226648.1 |
Bortezomib |
Skin cutaneous melanoma |
0.010756667 |
Resistant |
| ENSG00000227110.2 |
Bortezomib |
Skin cutaneous melanoma |
0.046391696 |
Resistant |
| ENSG00000227372.6 |
Bortezomib |
Skin cutaneous melanoma |
0.042370472 |
Resistant |
| ENSG00000227719.1 |
Bortezomib |
Skin cutaneous melanoma |
0.018308077 |
Resistant |
| ENSG00000228204.2 |
Bortezomib |
Skin cutaneous melanoma |
0.024243607 |
Resistant |
| ENSG00000230084.1 |
Bortezomib |
Skin cutaneous melanoma |
0.019713735 |
Resistant |
| ENSG00000230937.5 |
Bortezomib |
Skin cutaneous melanoma |
0.014831691 |
Resistant |
| ENSG00000231355.1 |
Bortezomib |
Skin cutaneous melanoma |
0.010209355 |
Resistant |
| ENSG00000231856.1 |
Bortezomib |
Skin cutaneous melanoma |
0.032583542 |
Resistant |
| ENSG00000231999.2 |
Bortezomib |
Skin cutaneous melanoma |
0.009518026 |
Resistant |
| ENSG00000233806.3 |
Bortezomib |
Skin cutaneous melanoma |
0.032291102 |
Resistant |
| ENSG00000233864.3 |
Bortezomib |
Skin cutaneous melanoma |
0.026178884 |
Resistant |
| ENSG00000234084.1 |
Bortezomib |
Skin cutaneous melanoma |
0.022140894 |
Resistant |
| ENSG00000234449.2 |
Bortezomib |
Skin cutaneous melanoma |
0.040986735 |
Resistant |
| ENSG00000237436.1 |
Bortezomib |
Skin cutaneous melanoma |
0.023691498 |
Resistant |
| ENSG00000245080.4 |
Bortezomib |
Skin cutaneous melanoma |
0.004610787 |
Resistant |
| ENSG00000245571.2 |
Bortezomib |
Skin cutaneous melanoma |
0.005125565 |
Resistant |
| ENSG00000249532.2 |
Bortezomib |
Skin cutaneous melanoma |
0.021792773 |
Resistant |
| ENSG00000253230.2 |
Bortezomib |
Skin cutaneous melanoma |
0.028583806 |
Resistant |
| ENSG00000253317.1 |
Bortezomib |
Skin cutaneous melanoma |
0.032168868 |
Resistant |
| ENSG00000255139.1 |
Bortezomib |
Skin cutaneous melanoma |
0.018658378 |
Resistant |
| ENSG00000255337.1 |
Bortezomib |
Skin cutaneous melanoma |
0.041886601 |
Resistant |
| ENSG00000259065.1 |
Bortezomib |
Skin cutaneous melanoma |
0.043112648 |
Resistant |
| ENSG00000259081.1 |
Bortezomib |
Skin cutaneous melanoma |
0.012405402 |
Resistant |
| ENSG00000259668.1 |
Bortezomib |
Skin cutaneous melanoma |
0.018988529 |
Resistant |
| ENSG00000259736.1 |
Bortezomib |
Skin cutaneous melanoma |
0.01994986 |
Resistant |
| ENSG00000259767.1 |
Bortezomib |
Skin cutaneous melanoma |
0.020224879 |
Resistant |
| ENSG00000260891.1 |
Bortezomib |
Skin cutaneous melanoma |
0.038297778 |
Resistant |
| ENSG00000261723.1 |
Bortezomib |
Skin cutaneous melanoma |
0.021635357 |
Resistant |
| ENSG00000261827.1 |
Bortezomib |
Skin cutaneous melanoma |
0.043417508 |
Resistant |
| ENSG00000262098.1 |
Bortezomib |
Skin cutaneous melanoma |
0.026652341 |
Resistant |
| ENSG00000262152.2 |
Bortezomib |
Skin cutaneous melanoma |
0.013421371 |
Resistant |
| ENSG00000267150.1 |
Bortezomib |
Skin cutaneous melanoma |
0.038060366 |
Resistant |
| ENSG00000267194.1 |
Bortezomib |
Skin cutaneous melanoma |
0.008503482 |
Resistant |
| ENSG00000267280.1 |
Bortezomib |
Skin cutaneous melanoma |
0.042609442 |
Resistant |
| ENSG00000267366.1 |
Bortezomib |
Skin cutaneous melanoma |
0.036343771 |
Resistant |
| ENSG00000269999.1 |
Bortezomib |
Skin cutaneous melanoma |
0.039332543 |
Resistant |
| ENSG00000270048.1 |
Bortezomib |
Skin cutaneous melanoma |
0.008368257 |
Resistant |
| ENSG00000271032.1 |
Bortezomib |
Skin cutaneous melanoma |
0.046258575 |
Resistant |
| ENSG00000272810.1 |
Bortezomib |
Skin cutaneous melanoma |
0.029637852 |
Resistant |
| ENSG00000272864.1 |
Bortezomib |
Skin cutaneous melanoma |
0.016555976 |
Resistant |
| ENSG00000182057.4 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037094989 |
Sensitive |
| ENSG00000182109.3 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024325333 |
Sensitive |
| ENSG00000197989.9 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016040445 |
Sensitive |
| ENSG00000213742.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011904908 |
Sensitive |
| ENSG00000224764.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029648213 |
Sensitive |
| ENSG00000224844.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022781392 |
Sensitive |
| ENSG00000225037.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048549013 |
Sensitive |
| ENSG00000228649.4 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016087747 |
Sensitive |
| ENSG00000228838.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03236282 |
Sensitive |
| ENSG00000229267.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040853424 |
Sensitive |
| ENSG00000230023.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019079688 |
Sensitive |
| ENSG00000231073.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033556779 |
Sensitive |
| ENSG00000231621.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031889011 |
Sensitive |
| ENSG00000231865.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003332195 |
Sensitive |
| ENSG00000231977.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018091319 |
Sensitive |
| ENSG00000232162.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017922532 |
Sensitive |
| ENSG00000232762.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001747325 |
Sensitive |
| ENSG00000233825.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005353073 |
Sensitive |
| ENSG00000234185.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000338486 |
Sensitive |
| ENSG00000235066.4 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043293003 |
Sensitive |
| ENSG00000235121.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044106786 |
Sensitive |
| ENSG00000235298.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024843211 |
Sensitive |
| ENSG00000235910.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049248708 |
Sensitive |
| ENSG00000236472.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023496743 |
Sensitive |
| ENSG00000237015.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041611952 |
Sensitive |
| ENSG00000237126.4 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047140863 |
Sensitive |
| ENSG00000237737.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041290013 |
Sensitive |
| ENSG00000239002.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022391933 |
Sensitive |
| ENSG00000240015.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039411689 |
Sensitive |
| ENSG00000240766.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019542925 |
Sensitive |
| ENSG00000242125.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048022852 |
Sensitive |
| ENSG00000242349.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036279014 |
Sensitive |
| ENSG00000244268.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045709295 |
Sensitive |
| ENSG00000248152.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042789058 |
Sensitive |
| ENSG00000249753.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019272172 |
Sensitive |
| ENSG00000250734.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010471894 |
Sensitive |
| ENSG00000250917.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028320685 |
Sensitive |
| ENSG00000251532.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044823882 |
Sensitive |
| ENSG00000251687.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037516862 |
Sensitive |
| ENSG00000253825.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035753108 |
Sensitive |
| ENSG00000254180.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007572696 |
Sensitive |
| ENSG00000254431.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03532019 |
Sensitive |
| ENSG00000254739.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027806629 |
Sensitive |
| ENSG00000255002.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017393769 |
Sensitive |
| ENSG00000255234.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03352441 |
Sensitive |
| ENSG00000255741.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044712583 |
Sensitive |
| ENSG00000255992.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023087188 |
Sensitive |
| ENSG00000256603.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019034506 |
Sensitive |
| ENSG00000257947.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010605926 |
Sensitive |
| ENSG00000259081.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02617025 |
Sensitive |
| ENSG00000259774.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041130121 |
Sensitive |
| ENSG00000259926.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01718773 |
Sensitive |
| ENSG00000260156.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016649654 |
Sensitive |
| ENSG00000260929.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020181823 |
Sensitive |
| ENSG00000261373.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007568438 |
Sensitive |
| ENSG00000261644.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029586472 |
Sensitive |
| ENSG00000261731.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030656542 |
Sensitive |
| ENSG00000264577.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000594925 |
Sensitive |
| ENSG00000265206.2 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020264543 |
Sensitive |
| ENSG00000266236.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039156104 |
Sensitive |
| ENSG00000266290.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020165218 |
Sensitive |
| ENSG00000266936.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031972242 |
Sensitive |
| ENSG00000266941.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038896537 |
Sensitive |
| ENSG00000267141.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000359493 |
Sensitive |
| ENSG00000267437.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023450211 |
Sensitive |
| ENSG00000267479.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027784156 |
Sensitive |
| ENSG00000267522.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018372899 |
Sensitive |
| ENSG00000267567.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042869338 |
Sensitive |
| ENSG00000269148.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008963461 |
Sensitive |
| ENSG00000269352.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016814157 |
Sensitive |
| ENSG00000270031.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045937006 |
Sensitive |
| ENSG00000270072.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01885113 |
Sensitive |
| ENSG00000271778.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049041575 |
Sensitive |
| ENSG00000272273.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01414749 |
Sensitive |
| ENSG00000272432.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037993474 |
Sensitive |
| ENSG00000272960.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045262978 |
Sensitive |
| ENSG00000273068.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017753011 |
Sensitive |
| ENSG00000273308.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042583439 |
Sensitive |
| ENSG00000273367.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025534624 |
Sensitive |
| ENSG00000273488.1 |
Bortezomib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010438818 |
Sensitive |
| ENSG00000152487.6 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.015607517 |
Sensitive |
| ENSG00000166770.6 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040472278 |
Sensitive |
| ENSG00000177337.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.006338739 |
Sensitive |
| ENSG00000177757.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001585563 |
Sensitive |
| ENSG00000182366.5 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014999078 |
Sensitive |
| ENSG00000204623.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.003372495 |
Sensitive |
| ENSG00000204706.10 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.037118282 |
Sensitive |
| ENSG00000205041.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.030584916 |
Sensitive |
| ENSG00000205885.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.015745238 |
Sensitive |
| ENSG00000213971.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.017882434 |
Sensitive |
| ENSG00000214894.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049821271 |
Sensitive |
| ENSG00000223882.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.008800377 |
Sensitive |
| ENSG00000223946.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049948741 |
Sensitive |
| ENSG00000224063.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.015127797 |
Sensitive |
| ENSG00000224490.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.030988586 |
Sensitive |
| ENSG00000224707.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034136459 |
Sensitive |
| ENSG00000224843.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.04051526 |
Sensitive |
| ENSG00000224888.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020809318 |
Sensitive |
| ENSG00000225075.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039448355 |
Sensitive |
| ENSG00000225767.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.02262461 |
Sensitive |
| ENSG00000225945.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.04831733 |
Sensitive |
| ENSG00000225948.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049025346 |
Sensitive |
| ENSG00000226009.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039207635 |
Sensitive |
| ENSG00000226263.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.016176015 |
Sensitive |
| ENSG00000226266.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.017809094 |
Sensitive |
| ENSG00000226310.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011950775 |
Sensitive |
| ENSG00000226330.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.047404962 |
Sensitive |
| ENSG00000226381.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001321814 |
Sensitive |
| ENSG00000226669.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021319262 |
Sensitive |
| ENSG00000226676.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043655969 |
Sensitive |
| ENSG00000226889.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.00615869 |
Sensitive |
| ENSG00000227014.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011305545 |
Sensitive |
| ENSG00000227165.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.028390828 |
Sensitive |
| ENSG00000227256.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.032676964 |
Sensitive |
| ENSG00000227388.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.035266263 |
Sensitive |
| ENSG00000227409.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021592807 |
Sensitive |
| ENSG00000227486.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049457809 |
Sensitive |
| ENSG00000227885.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.02626074 |
Sensitive |
| ENSG00000228028.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.005161731 |
Sensitive |
| ENSG00000228065.6 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014907943 |
Sensitive |
| ENSG00000228079.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018614642 |
Sensitive |
| ENSG00000228274.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025803641 |
Sensitive |
| ENSG00000228382.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012754056 |
Sensitive |
| ENSG00000228397.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.045624959 |
Sensitive |
| ENSG00000228436.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.038800997 |
Sensitive |
| ENSG00000228614.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011901272 |
Sensitive |
| ENSG00000228763.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.03738393 |
Sensitive |
| ENSG00000228794.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018092512 |
Sensitive |
| ENSG00000228906.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.048863233 |
Sensitive |
| ENSG00000229167.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049840301 |
Sensitive |
| ENSG00000229776.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039456655 |
Sensitive |
| ENSG00000231074.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001886506 |
Sensitive |
| ENSG00000231407.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.002514078 |
Sensitive |
| ENSG00000231512.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025557403 |
Sensitive |
| ENSG00000231769.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.008038525 |
Sensitive |
| ENSG00000231842.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.041531346 |
Sensitive |
| ENSG00000232104.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.015491023 |
Sensitive |
| ENSG00000232110.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.035046199 |
Sensitive |
| ENSG00000232470.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.038343598 |
Sensitive |
| ENSG00000232545.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.035626685 |
Sensitive |
| ENSG00000232855.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.047505201 |
Sensitive |
| ENSG00000232874.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025176161 |
Sensitive |
| ENSG00000232907.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011722612 |
Sensitive |
| ENSG00000232909.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.042977692 |
Sensitive |
| ENSG00000233509.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011467774 |
Sensitive |
| ENSG00000233627.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.008933426 |
Sensitive |
| ENSG00000233806.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.03842336 |
Sensitive |
| ENSG00000233834.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.019061805 |
Sensitive |
| ENSG00000233885.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.037241939 |
Sensitive |
| ENSG00000234281.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.00682917 |
Sensitive |
| ENSG00000234492.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.024151645 |
Sensitive |
| ENSG00000234509.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043666011 |
Sensitive |
| ENSG00000234978.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.03977173 |
Sensitive |
| ENSG00000235262.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.044232745 |
Sensitive |
| ENSG00000235326.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012077634 |
Sensitive |
| ENSG00000235373.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.017696765 |
Sensitive |
| ENSG00000235629.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.038070984 |
Sensitive |
| ENSG00000235772.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.044949192 |
Sensitive |
| ENSG00000235781.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034333263 |
Sensitive |
| ENSG00000236194.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.04627326 |
Sensitive |
| ENSG00000236299.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020593509 |
Sensitive |
| ENSG00000237021.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.046456403 |
Sensitive |
| ENSG00000237248.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.042513139 |
Sensitive |
| ENSG00000237338.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.03264979 |
Sensitive |
| ENSG00000237485.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.036858497 |
Sensitive |
| ENSG00000237491.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.000811409 |
Sensitive |
| ENSG00000237737.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.009865559 |
Sensitive |
| ENSG00000237786.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.013941637 |
Sensitive |
| ENSG00000238197.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.044320793 |
Sensitive |
| ENSG00000239653.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034374543 |
Sensitive |
| ENSG00000239906.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.01742729 |
Sensitive |
| ENSG00000239920.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012354032 |
Sensitive |
| ENSG00000240137.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040538865 |
Sensitive |
| ENSG00000240453.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.002134812 |
Sensitive |
| ENSG00000241860.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.010780183 |
Sensitive |
| ENSG00000243485.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.033747896 |
Sensitive |
| ENSG00000243701.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014331933 |
Sensitive |
| ENSG00000244265.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020324148 |
Sensitive |
| ENSG00000245146.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.047190254 |
Sensitive |
| ENSG00000245275.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.022203034 |
Sensitive |
| ENSG00000245598.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.022070733 |
Sensitive |
| ENSG00000245685.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.047524081 |
Sensitive |
| ENSG00000245849.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018706113 |
Sensitive |
| ENSG00000246225.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.009700349 |
Sensitive |
| ENSG00000247137.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.029668205 |
Sensitive |
| ENSG00000247199.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.032310869 |
Sensitive |
| ENSG00000247708.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018386846 |
Sensitive |
| ENSG00000247925.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.024955583 |
Sensitive |
| ENSG00000248399.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049261387 |
Sensitive |
| ENSG00000248668.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.004934354 |
Sensitive |
| ENSG00000248968.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020179474 |
Sensitive |
| ENSG00000249476.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.01108562 |
Sensitive |
| ENSG00000249502.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.004498765 |
Sensitive |
| ENSG00000249868.4 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014630157 |
Sensitive |
| ENSG00000250106.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.029589271 |
Sensitive |
| ENSG00000250159.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014964571 |
Sensitive |
| ENSG00000250220.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.032022445 |
Sensitive |
| ENSG00000250751.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.002270902 |
Sensitive |
| ENSG00000250950.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012573344 |
Sensitive |
| ENSG00000251600.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.008994799 |
Sensitive |
| ENSG00000253374.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001871052 |
Sensitive |
| ENSG00000253586.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.0494702 |
Sensitive |
| ENSG00000253708.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.013999104 |
Sensitive |
| ENSG00000253736.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012671256 |
Sensitive |
| ENSG00000253829.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.026851543 |
Sensitive |
| ENSG00000253853.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.030042956 |
Sensitive |
| ENSG00000253859.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001855085 |
Sensitive |
| ENSG00000253911.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043430161 |
Sensitive |
| ENSG00000254319.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021805944 |
Sensitive |
| ENSG00000254340.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.006803339 |
Sensitive |
| ENSG00000254362.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.049892495 |
Sensitive |
| ENSG00000254459.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040821823 |
Sensitive |
| ENSG00000254602.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.031803174 |
Sensitive |
| ENSG00000254691.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.008303911 |
Sensitive |
| ENSG00000254693.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040009853 |
Sensitive |
| ENSG00000254694.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034420648 |
Sensitive |
| ENSG00000255079.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.026971752 |
Sensitive |
| ENSG00000255089.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025245135 |
Sensitive |
| ENSG00000255092.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.045462132 |
Sensitive |
| ENSG00000255145.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.036694298 |
Sensitive |
| ENSG00000255240.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.013335831 |
Sensitive |
| ENSG00000255328.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.047257225 |
Sensitive |
| ENSG00000255449.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.007630658 |
Sensitive |
| ENSG00000255474.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040976926 |
Sensitive |
| ENSG00000255509.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025869365 |
Sensitive |
| ENSG00000255669.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011908363 |
Sensitive |
| ENSG00000255893.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011884471 |
Sensitive |
| ENSG00000256452.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043773785 |
Sensitive |
| ENSG00000256603.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.000722281 |
Sensitive |
| ENSG00000256789.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039232501 |
Sensitive |
| ENSG00000256967.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.013442736 |
Sensitive |
| ENSG00000257052.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025784109 |
Sensitive |
| ENSG00000257151.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040034745 |
Sensitive |
| ENSG00000257298.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034981213 |
Sensitive |
| ENSG00000257647.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.022162738 |
Sensitive |
| ENSG00000257964.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001288986 |
Sensitive |
| ENSG00000258851.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.015662112 |
Sensitive |
| ENSG00000259039.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.022316929 |
Sensitive |
| ENSG00000259212.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021849494 |
Sensitive |
| ENSG00000259366.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014134836 |
Sensitive |
| ENSG00000259418.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.006530975 |
Sensitive |
| ENSG00000259453.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.033139458 |
Sensitive |
| ENSG00000259499.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043206889 |
Sensitive |
| ENSG00000259553.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.014885847 |
Sensitive |
| ENSG00000259881.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040685064 |
Sensitive |
| ENSG00000259972.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020839643 |
Sensitive |
| ENSG00000260000.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.030153046 |
Sensitive |
| ENSG00000260194.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.037227145 |
Sensitive |
| ENSG00000260252.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.036853646 |
Sensitive |
| ENSG00000260367.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018508393 |
Sensitive |
| ENSG00000260589.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.003508491 |
Sensitive |
| ENSG00000260641.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.026773615 |
Sensitive |
| ENSG00000260671.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.02755468 |
Sensitive |
| ENSG00000260884.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.029585179 |
Sensitive |
| ENSG00000261002.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.035775688 |
Sensitive |
| ENSG00000261040.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.022748808 |
Sensitive |
| ENSG00000261079.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.024972384 |
Sensitive |
| ENSG00000261094.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012619973 |
Sensitive |
| ENSG00000261096.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.027827126 |
Sensitive |
| ENSG00000261158.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021853392 |
Sensitive |
| ENSG00000261360.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.031650339 |
Sensitive |
| ENSG00000261366.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.004291333 |
Sensitive |
| ENSG00000261584.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025147604 |
Sensitive |
| ENSG00000261695.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021136621 |
Sensitive |
| ENSG00000261737.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.005947024 |
Sensitive |
| ENSG00000261872.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039520284 |
Sensitive |
| ENSG00000262001.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018706327 |
Sensitive |
| ENSG00000262412.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.044346575 |
Sensitive |
| ENSG00000262663.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039553997 |
Sensitive |
| ENSG00000262766.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.04207576 |
Sensitive |
| ENSG00000262973.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.01864536 |
Sensitive |
| ENSG00000263370.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.032238546 |
Sensitive |
| ENSG00000263766.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.018350976 |
Sensitive |
| ENSG00000263916.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.045210696 |
Sensitive |
| ENSG00000264078.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.016998126 |
Sensitive |
| ENSG00000264339.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.027713582 |
Sensitive |
| ENSG00000264635.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020647233 |
Sensitive |
| ENSG00000265451.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.015950609 |
Sensitive |
| ENSG00000265666.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.005151067 |
Sensitive |
| ENSG00000265992.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021809245 |
Sensitive |
| ENSG00000266236.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.020894339 |
Sensitive |
| ENSG00000266237.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.04458803 |
Sensitive |
| ENSG00000266903.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.036270985 |
Sensitive |
| ENSG00000267002.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.006876917 |
Sensitive |
| ENSG00000267003.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034346403 |
Sensitive |
| ENSG00000267044.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.036153093 |
Sensitive |
| ENSG00000267118.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.001610356 |
Sensitive |
| ENSG00000267121.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034847688 |
Sensitive |
| ENSG00000267248.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025917356 |
Sensitive |
| ENSG00000267344.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.008208598 |
Sensitive |
| ENSG00000267345.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.03004966 |
Sensitive |
| ENSG00000267374.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.038802225 |
Sensitive |
| ENSG00000267416.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.040282271 |
Sensitive |
| ENSG00000267454.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.031167679 |
Sensitive |
| ENSG00000267758.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.041689312 |
Sensitive |
| ENSG00000268316.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043176606 |
Sensitive |
| ENSG00000268364.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.007727717 |
Sensitive |
| ENSG00000268471.3 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021807303 |
Sensitive |
| ENSG00000268743.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.045491726 |
Sensitive |
| ENSG00000269091.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.021014693 |
Sensitive |
| ENSG00000269107.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.003551562 |
Sensitive |
| ENSG00000269290.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.042808934 |
Sensitive |
| ENSG00000269303.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.034701327 |
Sensitive |
| ENSG00000269444.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.007772586 |
Sensitive |
| ENSG00000269997.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.006960412 |
Sensitive |
| ENSG00000270048.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.000645886 |
Sensitive |
| ENSG00000270061.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.026059553 |
Sensitive |
| ENSG00000270095.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.012206053 |
Sensitive |
| ENSG00000270105.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.017683909 |
Sensitive |
| ENSG00000270523.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.028714837 |
Sensitive |
| ENSG00000270751.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.023860138 |
Sensitive |
| ENSG00000271347.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.031160591 |
Sensitive |
| ENSG00000271576.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.032508824 |
Sensitive |
| ENSG00000271856.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.026604191 |
Sensitive |
| ENSG00000272053.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.011531319 |
Sensitive |
| ENSG00000272240.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.041240317 |
Sensitive |
| ENSG00000272320.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.046410319 |
Sensitive |
| ENSG00000272462.2 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.000132053 |
Sensitive |
| ENSG00000272489.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.002898094 |
Sensitive |
| ENSG00000272508.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.006606795 |
Sensitive |
| ENSG00000272558.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.007464422 |
Sensitive |
| ENSG00000272562.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.041807591 |
Sensitive |
| ENSG00000272735.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.043221783 |
Sensitive |
| ENSG00000272810.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.039079904 |
Sensitive |
| ENSG00000272933.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.025403636 |
Sensitive |
| ENSG00000273076.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.022917442 |
Sensitive |
| ENSG00000273113.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.045910877 |
Sensitive |
| ENSG00000273350.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.044302832 |
Sensitive |
| ENSG00000273448.1 |
Bortezomib |
Chronic Lymphocytic Leukemia |
0.04448073 |
Sensitive |
| ENSG00000175967.3 |
Bortezomib |
Brain lower grade glioma |
0.001835846 |
Sensitive |
| ENSG00000177738.3 |
Bortezomib |
Brain lower grade glioma |
0.032390521 |
Sensitive |
| ENSG00000183535.5 |
Bortezomib |
Brain lower grade glioma |
0.013472218 |
Sensitive |
| ENSG00000184274.3 |
Bortezomib |
Brain lower grade glioma |
0.036314025 |
Sensitive |
| ENSG00000188365.3 |
Bortezomib |
Brain lower grade glioma |
0.023685672 |
Sensitive |
| ENSG00000203706.4 |
Bortezomib |
Brain lower grade glioma |
0.048258947 |
Sensitive |
| ENSG00000205890.3 |
Bortezomib |
Brain lower grade glioma |
0.011591488 |
Sensitive |
| ENSG00000223401.1 |
Bortezomib |
Brain lower grade glioma |
0.042567705 |
Sensitive |
| ENSG00000225177.1 |
Bortezomib |
Brain lower grade glioma |
0.003387159 |
Sensitive |
| ENSG00000225407.3 |
Bortezomib |
Brain lower grade glioma |
0.038602184 |
Sensitive |
| ENSG00000226089.2 |
Bortezomib |
Brain lower grade glioma |
0.034021914 |
Sensitive |
| ENSG00000226520.1 |
Bortezomib |
Brain lower grade glioma |
0.013501086 |
Sensitive |
| ENSG00000227036.2 |
Bortezomib |
Brain lower grade glioma |
0.008627778 |
Sensitive |
| ENSG00000227192.1 |
Bortezomib |
Brain lower grade glioma |
0.024632597 |
Sensitive |
| ENSG00000227400.2 |
Bortezomib |
Brain lower grade glioma |
0.007593327 |
Sensitive |
| ENSG00000227438.1 |
Bortezomib |
Brain lower grade glioma |
0.025313757 |
Sensitive |
| ENSG00000227496.1 |
Bortezomib |
Brain lower grade glioma |
0.039163933 |
Sensitive |
| ENSG00000228021.3 |
Bortezomib |
Brain lower grade glioma |
0.020417837 |
Sensitive |
| ENSG00000229931.1 |
Bortezomib |
Brain lower grade glioma |
0.011058349 |
Sensitive |
| ENSG00000230798.1 |
Bortezomib |
Brain lower grade glioma |
0.006695415 |
Sensitive |
| ENSG00000232043.1 |
Bortezomib |
Brain lower grade glioma |
0.040963147 |
Sensitive |
| ENSG00000232725.1 |
Bortezomib |
Brain lower grade glioma |
0.041936946 |
Sensitive |
| ENSG00000233783.3 |
Bortezomib |
Brain lower grade glioma |
0.046641459 |
Sensitive |
| ENSG00000234459.1 |
Bortezomib |
Brain lower grade glioma |
0.03336821 |
Sensitive |
| ENSG00000234703.1 |
Bortezomib |
Brain lower grade glioma |
0.049672168 |
Sensitive |
| ENSG00000235423.4 |
Bortezomib |
Brain lower grade glioma |
0.022498568 |
Sensitive |
| ENSG00000237181.1 |
Bortezomib |
Brain lower grade glioma |
0.045643296 |
Sensitive |
| ENSG00000237520.1 |
Bortezomib |
Brain lower grade glioma |
0.023314804 |
Sensitive |
| ENSG00000238078.1 |
Bortezomib |
Brain lower grade glioma |
0.007088496 |
Sensitive |
| ENSG00000244203.2 |
Bortezomib |
Brain lower grade glioma |
0.000926925 |
Sensitive |
| ENSG00000244468.1 |
Bortezomib |
Brain lower grade glioma |
0.03582641 |
Sensitive |
| ENSG00000249669.3 |
Bortezomib |
Brain lower grade glioma |
0.021716465 |
Sensitive |
| ENSG00000249740.1 |
Bortezomib |
Brain lower grade glioma |
0.025699981 |
Sensitive |
| ENSG00000250320.1 |
Bortezomib |
Brain lower grade glioma |
0.033024331 |
Sensitive |
| ENSG00000251445.1 |
Bortezomib |
Brain lower grade glioma |
0.032542207 |
Sensitive |
| ENSG00000251661.3 |
Bortezomib |
Brain lower grade glioma |
0.043351513 |
Sensitive |
| ENSG00000253737.1 |
Bortezomib |
Brain lower grade glioma |
0.048569401 |
Sensitive |
| ENSG00000253864.1 |
Bortezomib |
Brain lower grade glioma |
0.025497669 |
Sensitive |
| ENSG00000254003.1 |
Bortezomib |
Brain lower grade glioma |
0.045873957 |
Sensitive |
| ENSG00000254847.1 |
Bortezomib |
Brain lower grade glioma |
0.024735903 |
Sensitive |
| ENSG00000255176.1 |
Bortezomib |
Brain lower grade glioma |
0.020157339 |
Sensitive |
| ENSG00000255343.1 |
Bortezomib |
Brain lower grade glioma |
0.015467276 |
Sensitive |
| ENSG00000255509.2 |
Bortezomib |
Brain lower grade glioma |
0.04941948 |
Sensitive |
| ENSG00000255557.1 |
Bortezomib |
Brain lower grade glioma |
0.012053078 |
Sensitive |
| ENSG00000257298.1 |
Bortezomib |
Brain lower grade glioma |
0.020766553 |
Sensitive |
| ENSG00000259542.1 |
Bortezomib |
Brain lower grade glioma |
0.025522269 |
Sensitive |
| ENSG00000260630.2 |
Bortezomib |
Brain lower grade glioma |
0.013146601 |
Sensitive |
| ENSG00000260744.1 |
Bortezomib |
Brain lower grade glioma |
0.007740155 |
Sensitive |
| ENSG00000261055.1 |
Bortezomib |
Brain lower grade glioma |
0.040387013 |
Sensitive |
| ENSG00000261064.1 |
Bortezomib |
Brain lower grade glioma |
0.008781621 |
Sensitive |
| ENSG00000262179.2 |
Bortezomib |
Brain lower grade glioma |
0.031460224 |
Sensitive |
| ENSG00000263393.1 |
Bortezomib |
Brain lower grade glioma |
0.03023162 |
Sensitive |
| ENSG00000263680.2 |
Bortezomib |
Brain lower grade glioma |
0.014031985 |
Sensitive |
| ENSG00000264188.1 |
Bortezomib |
Brain lower grade glioma |
0.046687689 |
Sensitive |
| ENSG00000272341.1 |
Bortezomib |
Brain lower grade glioma |
0.024188674 |
Sensitive |
| ENSG00000132832.5 |
Bortezomib |
Lung squamous cell carcinoma |
0.040669453 |
Sensitive |
| ENSG00000152487.6 |
Bortezomib |
Lung squamous cell carcinoma |
0.034736084 |
Sensitive |
| ENSG00000203999.4 |
Bortezomib |
Lung squamous cell carcinoma |
0.04243933 |
Sensitive |
| ENSG00000204362.5 |
Bortezomib |
Lung squamous cell carcinoma |
0.042406519 |
Sensitive |
| ENSG00000205885.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.011866863 |
Sensitive |
| ENSG00000213793.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.037814464 |
Sensitive |
| ENSG00000213904.4 |
Bortezomib |
Lung squamous cell carcinoma |
0.001796086 |
Sensitive |
| ENSG00000215859.4 |
Bortezomib |
Lung squamous cell carcinoma |
0.017985587 |
Sensitive |
| ENSG00000221817.5 |
Bortezomib |
Lung squamous cell carcinoma |
0.011284141 |
Sensitive |
| ENSG00000223477.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.03792738 |
Sensitive |
| ENSG00000223695.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.036151922 |
Sensitive |
| ENSG00000223829.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.047898871 |
Sensitive |
| ENSG00000224020.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.030101674 |
Sensitive |
| ENSG00000224596.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.035875069 |
Sensitive |
| ENSG00000224812.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.008144226 |
Sensitive |
| ENSG00000225790.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.023927151 |
Sensitive |
| ENSG00000225913.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.043595936 |
Sensitive |
| ENSG00000226328.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.014651447 |
Sensitive |
| ENSG00000226548.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.019889875 |
Sensitive |
| ENSG00000227110.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.016180078 |
Sensitive |
| ENSG00000227702.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.027576671 |
Sensitive |
| ENSG00000228107.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.028565796 |
Sensitive |
| ENSG00000228242.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.016609917 |
Sensitive |
| ENSG00000229109.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048950492 |
Sensitive |
| ENSG00000229190.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.003134904 |
Sensitive |
| ENSG00000229463.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.04414444 |
Sensitive |
| ENSG00000230084.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.002477837 |
Sensitive |
| ENSG00000230105.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.019187247 |
Sensitive |
| ENSG00000231290.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.044335221 |
Sensitive |
| ENSG00000231638.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.043705087 |
Sensitive |
| ENSG00000231969.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.025197133 |
Sensitive |
| ENSG00000232324.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.040849526 |
Sensitive |
| ENSG00000232480.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.006727869 |
Sensitive |
| ENSG00000232555.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.02896288 |
Sensitive |
| ENSG00000232756.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.025830011 |
Sensitive |
| ENSG00000233006.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.02990919 |
Sensitive |
| ENSG00000233029.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.032778675 |
Sensitive |
| ENSG00000233033.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.045758265 |
Sensitive |
| ENSG00000233077.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048540707 |
Sensitive |
| ENSG00000233429.5 |
Bortezomib |
Lung squamous cell carcinoma |
0.028959774 |
Sensitive |
| ENSG00000233602.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.040793789 |
Sensitive |
| ENSG00000233693.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.011209083 |
Sensitive |
| ENSG00000233818.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.047860483 |
Sensitive |
| ENSG00000233852.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.038334113 |
Sensitive |
| ENSG00000233926.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048875911 |
Sensitive |
| ENSG00000234136.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.021496345 |
Sensitive |
| ENSG00000234183.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.010613351 |
Sensitive |
| ENSG00000234936.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.030140805 |
Sensitive |
| ENSG00000234998.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.032261909 |
Sensitive |
| ENSG00000235770.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.039764874 |
Sensitive |
| ENSG00000235781.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.014299846 |
Sensitive |
| ENSG00000235823.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.046360787 |
Sensitive |
| ENSG00000235831.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.003872405 |
Sensitive |
| ENSG00000236451.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.02150094 |
Sensitive |
| ENSG00000236514.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.029122435 |
Sensitive |
| ENSG00000236591.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.020568936 |
Sensitive |
| ENSG00000236605.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.047739566 |
Sensitive |
| ENSG00000236658.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.044125599 |
Sensitive |
| ENSG00000236663.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048674516 |
Sensitive |
| ENSG00000236936.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.004196198 |
Sensitive |
| ENSG00000237998.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.007354492 |
Sensitive |
| ENSG00000238164.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.041162236 |
Sensitive |
| ENSG00000239920.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.045118198 |
Sensitive |
| ENSG00000242207.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.031769262 |
Sensitive |
| ENSG00000243415.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.026025108 |
Sensitive |
| ENSG00000245573.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.00378949 |
Sensitive |
| ENSG00000248223.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.022255949 |
Sensitive |
| ENSG00000248494.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.033074319 |
Sensitive |
| ENSG00000248690.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.02882474 |
Sensitive |
| ENSG00000248980.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.034224393 |
Sensitive |
| ENSG00000249610.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.022085435 |
Sensitive |
| ENSG00000250240.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.014496595 |
Sensitive |
| ENSG00000250303.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.042319179 |
Sensitive |
| ENSG00000250320.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.031557552 |
Sensitive |
| ENSG00000250608.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.049631891 |
Sensitive |
| ENSG00000250842.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.026615519 |
Sensitive |
| ENSG00000251144.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.003080175 |
Sensitive |
| ENSG00000251417.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.036793091 |
Sensitive |
| ENSG00000251661.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.037632701 |
Sensitive |
| ENSG00000253263.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.028366333 |
Sensitive |
| ENSG00000253361.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.012896108 |
Sensitive |
| ENSG00000253552.3 |
Bortezomib |
Lung squamous cell carcinoma |
0.006519268 |
Sensitive |
| ENSG00000253701.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.03528693 |
Sensitive |
| ENSG00000253854.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.031863197 |
Sensitive |
| ENSG00000253859.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.024565642 |
Sensitive |
| ENSG00000253948.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.044390561 |
Sensitive |
| ENSG00000253955.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.012926466 |
Sensitive |
| ENSG00000254100.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.032100657 |
Sensitive |
| ENSG00000254418.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.031911834 |
Sensitive |
| ENSG00000254495.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.026057601 |
Sensitive |
| ENSG00000254847.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.032324595 |
Sensitive |
| ENSG00000255100.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.043358921 |
Sensitive |
| ENSG00000255322.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.036396943 |
Sensitive |
| ENSG00000255328.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.02830562 |
Sensitive |
| ENSG00000255355.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.045016762 |
Sensitive |
| ENSG00000255847.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.032561592 |
Sensitive |
| ENSG00000255980.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.018790822 |
Sensitive |
| ENSG00000256967.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.023548846 |
Sensitive |
| ENSG00000257221.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.031562982 |
Sensitive |
| ENSG00000257556.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.038405368 |
Sensitive |
| ENSG00000258279.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.029266359 |
Sensitive |
| ENSG00000258556.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048981749 |
Sensitive |
| ENSG00000258658.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048761672 |
Sensitive |
| ENSG00000258736.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.030749632 |
Sensitive |
| ENSG00000258910.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.042850729 |
Sensitive |
| ENSG00000259088.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.022007646 |
Sensitive |
| ENSG00000259158.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.022527393 |
Sensitive |
| ENSG00000259432.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.025087948 |
Sensitive |
| ENSG00000259644.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.002264389 |
Sensitive |
| ENSG00000259732.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.049509548 |
Sensitive |
| ENSG00000259810.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.009747631 |
Sensitive |
| ENSG00000259867.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.021585688 |
Sensitive |
| ENSG00000260430.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.044128404 |
Sensitive |
| ENSG00000260613.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.019814896 |
Sensitive |
| ENSG00000260796.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.025312437 |
Sensitive |
| ENSG00000260896.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.000837153 |
Sensitive |
| ENSG00000261019.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.007293328 |
Sensitive |
| ENSG00000261051.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.040154731 |
Sensitive |
| ENSG00000261396.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.026992839 |
Sensitive |
| ENSG00000261744.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.033636792 |
Sensitive |
| ENSG00000261760.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.019338214 |
Sensitive |
| ENSG00000262903.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.020558173 |
Sensitive |
| ENSG00000263220.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.041795538 |
Sensitive |
| ENSG00000263466.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.019033571 |
Sensitive |
| ENSG00000263874.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.029657435 |
Sensitive |
| ENSG00000263893.2 |
Bortezomib |
Lung squamous cell carcinoma |
0.021581758 |
Sensitive |
| ENSG00000264666.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.049945528 |
Sensitive |
| ENSG00000264673.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.017657916 |
Sensitive |
| ENSG00000264729.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.021297616 |
Sensitive |
| ENSG00000265519.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.0085002 |
Sensitive |
| ENSG00000265556.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.037848422 |
Sensitive |
| ENSG00000266904.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.033198285 |
Sensitive |
| ENSG00000266950.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.039563495 |
Sensitive |
| ENSG00000267143.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.007410054 |
Sensitive |
| ENSG00000267278.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.04783006 |
Sensitive |
| ENSG00000267581.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.024058015 |
Sensitive |
| ENSG00000268889.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.036467386 |
Sensitive |
| ENSG00000269051.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.014550662 |
Sensitive |
| ENSG00000269392.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.006457146 |
Sensitive |
| ENSG00000269646.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.022794234 |
Sensitive |
| ENSG00000269653.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.02488222 |
Sensitive |
| ENSG00000269656.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.033848253 |
Sensitive |
| ENSG00000269895.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.003159218 |
Sensitive |
| ENSG00000269959.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.020609799 |
Sensitive |
| ENSG00000270040.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.032492004 |
Sensitive |
| ENSG00000271382.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.02063043 |
Sensitive |
| ENSG00000271971.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.039147008 |
Sensitive |
| ENSG00000272070.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.005159961 |
Sensitive |
| ENSG00000272320.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.036691231 |
Sensitive |
| ENSG00000272668.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.013899963 |
Sensitive |
| ENSG00000272761.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.048915435 |
Sensitive |
| ENSG00000272789.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.047150356 |
Sensitive |
| ENSG00000272824.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.038123956 |
Sensitive |
| ENSG00000273123.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.031976968 |
Sensitive |
| ENSG00000273249.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.039338075 |
Sensitive |
| ENSG00000273424.1 |
Bortezomib |
Lung squamous cell carcinoma |
0.01742497 |
Sensitive |
| ENSG00000189149.7 |
Bortezomib |
Skin cutaneous melanoma |
0.045405505 |
Sensitive |
| ENSG00000204792.2 |
Bortezomib |
Skin cutaneous melanoma |
0.033653307 |
Sensitive |
| ENSG00000214559.3 |
Bortezomib |
Skin cutaneous melanoma |
0.034430194 |
Sensitive |
| ENSG00000223380.3 |
Bortezomib |
Skin cutaneous melanoma |
0.042163408 |
Sensitive |
| ENSG00000224189.2 |
Bortezomib |
Skin cutaneous melanoma |
0.016191096 |
Sensitive |
| ENSG00000224846.1 |
Bortezomib |
Skin cutaneous melanoma |
0.031678174 |
Sensitive |
| ENSG00000228288.2 |
Bortezomib |
Skin cutaneous melanoma |
0.00859502 |
Sensitive |
| ENSG00000228540.1 |
Bortezomib |
Skin cutaneous melanoma |
0.046200353 |
Sensitive |
| ENSG00000230010.1 |
Bortezomib |
Skin cutaneous melanoma |
0.004889244 |
Sensitive |
| ENSG00000230082.1 |
Bortezomib |
Skin cutaneous melanoma |
0.047451583 |
Sensitive |
| ENSG00000232063.1 |
Bortezomib |
Skin cutaneous melanoma |
0.011158364 |
Sensitive |
| ENSG00000232233.1 |
Bortezomib |
Skin cutaneous melanoma |
0.004001908 |
Sensitive |
| ENSG00000232756.1 |
Bortezomib |
Skin cutaneous melanoma |
0.037830054 |
Sensitive |
| ENSG00000235078.1 |
Bortezomib |
Skin cutaneous melanoma |
0.006419641 |
Sensitive |
| ENSG00000236990.1 |
Bortezomib |
Skin cutaneous melanoma |
0.001073679 |
Sensitive |
| ENSG00000240211.1 |
Bortezomib |
Skin cutaneous melanoma |
0.039497027 |
Sensitive |
| ENSG00000242154.1 |
Bortezomib |
Skin cutaneous melanoma |
0.032702151 |
Sensitive |
| ENSG00000251095.2 |
Bortezomib |
Skin cutaneous melanoma |
0.036013272 |
Sensitive |
| ENSG00000254990.1 |
Bortezomib |
Skin cutaneous melanoma |
0.047216229 |
Sensitive |
| ENSG00000256967.1 |
Bortezomib |
Skin cutaneous melanoma |
0.045599675 |
Sensitive |
| ENSG00000257681.1 |
Bortezomib |
Skin cutaneous melanoma |
0.028527558 |
Sensitive |
| ENSG00000258168.1 |
Bortezomib |
Skin cutaneous melanoma |
0.005563421 |
Sensitive |
| ENSG00000258940.2 |
Bortezomib |
Skin cutaneous melanoma |
0.009885602 |
Sensitive |
| ENSG00000259782.2 |
Bortezomib |
Skin cutaneous melanoma |
0.001312529 |
Sensitive |
| ENSG00000260136.1 |
Bortezomib |
Skin cutaneous melanoma |
0.032374725 |
Sensitive |
| ENSG00000260498.1 |
Bortezomib |
Skin cutaneous melanoma |
0.022246467 |
Sensitive |
| ENSG00000261373.1 |
Bortezomib |
Skin cutaneous melanoma |
0.04627651 |
Sensitive |
| ENSG00000268366.1 |
Bortezomib |
Skin cutaneous melanoma |
0.005328943 |
Sensitive |
| ENSG00000269535.1 |
Bortezomib |
Skin cutaneous melanoma |
0.034013028 |
Sensitive |
| ENSG00000270761.1 |
Bortezomib |
Skin cutaneous melanoma |
0.043186239 |
Sensitive |
| ENSG00000272446.1 |
Bortezomib |
Skin cutaneous melanoma |
0.025438402 |
Sensitive |
| ENSG00000272702.1 |
Bortezomib |
Skin cutaneous melanoma |
0.049759364 |
Sensitive |
| ENSG00000272966.1 |
Bortezomib |
Skin cutaneous melanoma |
0.028185706 |
Sensitive |
| ENSG00000273081.1 |
Bortezomib |
Skin cutaneous melanoma |
0.034815058 |
Sensitive |
